help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huynh, H. K.
Right arrow Articles by Dorovini-Zis, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huynh, H. K.
Right arrow Articles by Dorovini-Zis, K.

American Journal of Pathology, Vol 142, 1265-1278, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells

HK Huynh and K Dorovini-Zis
Department of Pathology, Vancouver General Hospital, British Columbia, Canada.

Primary cultures of human brain microvessel endothelial cells were used to study the effects of human recombinant interferon-gamma (IFN-gamma) on cerebral endothelium in vitro. Incubation of monolayers with various concentrations of IFN-gamma (10 to 200 U/ml) for 12 to 96 hours induced surface expression of class II major histocompatibility complex (Ia) antigen in a time- and concentration-dependent manner. In immunogold- stained cultures, labeling was observed as early as 12 hours, was maximal after 48 hours, and persisted at plateau levels in the continuous presence of the cytokine. Expression was blocked by coincubation with anti-IFN-gamma antibody and was reversed 4 days following removal of IFN-gamma from the culture media. Endothelial cells treated with IFN-gamma for 3 to 4 days became spindle-shaped, extensively overlapped, and frequently formed cellular whorls. These changes did not occur in the presence of anti-IFN-gamma antibody and reversed upon removal of IFN-gamma from the media. The morphological alterations were associated with increased permeability of confluent monolayers to macromolecules as compared with untreated cultures. The results of these studies indicate that human brain microvessel endothelial cells respond to in vitro cytokine stimulation by undergoing profound morphological, functional, and permeability changes. We conclude that cerebral endothelium may play an important role in the initiation and regulation of lymphocyte traffic across the blood-brain barrier in inflammatory disorders of the human central nervous system.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. Kerschensteiner, C. Stadelmann, B. S. Buddeberg, D. Merkler, F. M. Bareyre, D. C. Anthony, C. Linington, W. Bruck, and M. E. Schwab
Targeting Experimental Autoimmune Encephalomyelitis Lesions to a Predetermined Axonal Tract System Allows for Refined Behavioral Testing in an Animal Model of Multiple Sclerosis
Am. J. Pathol., April 1, 2004; 164(4): 1455 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. N. Kalaria
Cerebral Endothelial Activation and Signal Transduction Mechanisms during Inflammation and Infectious Disease
Am. J. Pathol., May 1, 1999; 154(5): 1311 - 1314.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Deckert-Schluter, H. Bluethmann, N. Kaefer, A. Rang, and D. Schluter
Interferon-{gamma} Receptor-Mediated but Not Tumor Necrosis Factor Receptor Type 1- or Type 2-Mediated Signaling Is Crucial for the Activation of Cerebral Blood Vessel Endothelial Cells and Microglia in Murine Toxoplasma Encephalitis
Am. J. Pathol., May 1, 1999; 154(5): 1549 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. E. d. Vries, J. Kuiper, A. G. d. Boer, T. J. C. V. Berkel, and D. D. Breimer
The Blood-Brain Barrier in Neuroinflammatory Diseases
Pharmacol. Rev., June 1, 1997; 49(2): 143 - 156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.